Results 261 to 270 of about 2,048,763 (395)
Strengthening ethical oversight in genomics and biobanking: a retrospective analysis of research practices in Zimbabwe. [PDF]
Kuguyo O+7 more
europepmc +1 more source
A frequent RFLP identified by a human proenkephalin genomic clone [HGM9 symbol PENK] [PDF]
M. Litt, A. Buder
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Publisher Correction: Analysis of R-loop forming regions identifies RNU2-2 and RNU5B-1 as neurodevelopmental disorder genes. [PDF]
Jackson A+22 more
europepmc +1 more source
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha+10 more
wiley +1 more source
Correction: A Mg<sup>2+</sup>-dependent high-yield method for extracting high-molecular-weight genomic DNA from a single planarian specimen. [PDF]
Li A+7 more
europepmc +1 more source
lincRNAs: Genomics, Evolution, and Mechanisms
I. Ulitsky, D. Bartel
semanticscholar +1 more source
Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban+12 more
wiley +1 more source